Genome-wide CRISPR-Cas9 screen identifies novel biomarkers to modulate Atovaquone sensitivity and resistance in ovarian cancer All Restricted

Ma, Mirielle (Spring 2025)

Permanent URL: https://etd.library.emory.edu/concern/etds/d791sh60g?locale=es

Published

This abstract is under embargo until 22 May 2027

This table of contents is under embargo until 22 May 2027

Rights statement

Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.

School	Emory College
Department	Biology
Degree	B.S.
Submission	Honors Thesis
Language	English
Research Field	Biology, Cell Health Sciences, Obstetrics and Gynecology Health Sciences, Oncology
Palabra Clave	Ovarian Cancer STAT3 Atovaquone
Committee Chair / Thesis Advisor	David Frank, MD, PhD, Emory University
Committee Members	Benjamin Barwick, PhD, Emory University Edward Nam, PhD, Emory University

Última modificación